🇺🇸 FDA
Patent

US 7135177

Immunoliposomes that optimize internalization into target cells

granted A61KA61K38/00A61K47/6849

Quick answer

US patent 7135177 (Immunoliposomes that optimize internalization into target cells) held by The Regents of the University of California expires Mon Nov 09 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Nov 14 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 09 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K38/00, A61K47/6849, A61K47/6913, A61K9/127